Healthcare entity
Every one of those 2 sits in a single category, regulation. US Centers for Disease Control and Prevention is most often covered alongside Africa Centres for Disease Control and Prevention, which appears in 2 of these 2 stories. The 13-day window averages about 1.1 stories each week.
Last mentioned: Jul 11, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 2 sits in a single category, regulation. US Centers for Disease Control and Prevention is most often covered alongside Africa Centres for Disease Control and Prevention, which appears in 2 of these 2 stories. The 13-day window averages about 1.1 stories each week. Each story carries 2 original sources on average, compared with 6.5 for the broader beat in this window. At 7, the average consequence score sits above the same-window beat average of 6.7. This profile follows 2 Healthcare stories mentioning US Centers for Disease Control and Prevention across the period from July 11, 2026 to July 23, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 100 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering US Centers for Disease Control and Prevention. Shared-story counts are live from our verified record — not editorial picks.
US aid worker tests positive
CDC confirms a US citizen aid worker in Congo has Ebola; contact tracing and containment measures initiated.
Record outbreak data confirmed
Africa CDC reports the outbreak as the fastest-growing ever at 1,830 confirmed cases and 648 deaths. U.S. aid worker infection announced by CDC.
Clinical trials for treatments launched
Researchers initiate a highly anticipated clinical study to test experimental therapies against the Bundibugyo virus.
Clinical trials for Ebola treatment begin
Researchers launch a highly anticipated study to test experimental therapies against the Bundibugyo strain.
Kenya court suspends U.S.-backed facility
A Kenyan court order halts construction of a U.S.-planned quarantine facility for Americans exposed abroad, complicating evacuation plans.
Kenya Ebola facility suspended
A Kenyan court orders suspension of construction on a US-backed isolation facility for exposed Americans, pausing Trump administration plans.
First US doctor infected
An American doctor working in Congo tests positive during outbreak's first week and is transferred to Germany for treatment.
Congo declares fresh Ebola outbreak
Authorities announce outbreak of Bundibugyo virus after weeks of undetected transmission, according to WHO.
Ebola outbreak officially declared
Congolese authorities declare a fresh Ebola outbreak after weeks of undetected transmission, as later confirmed by WHO.
First U.S. doctor infected and evacuated
An American doctor working in Congo tests positive for Ebola and is transferred to Germany for treatment during the outbreak’s first week.
The record Ebola outbreak in Congo surpasses 1,830 cases and 648 deaths, with a second U.S. humanitarian worker now infected. The public health response faces severe funding and security obstacles, while experimental treatments enter clinical trials.
The infection of a US aid worker in Congo's record Ebola outbreak starkly reveals the public health challenges: 1,830 confirmed cases, 648 deaths, and a rare strain with no approved countermeasures. The event tests global infection control, healthcare worker safety, and emergency data sharing.
US Centers for Disease Control and Prevention is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
